Important Safety Information
Prescribing Information
Patient Support
Visit Our Patient Site
Prescribing Information Patient Websites

Visit Patient Site

IMPORTANT SAFETY INFORMATION:

Sucraid® Single-Use Container

Take It With You!

Introducing Sucraid® Single-Use Container. A convenient way for patients to travel with and take Sucraid®.

In This Section

Discover the Convenience of Sucraid® Single-Use Container

  • Three-day room temperature stability
    59°F to 77°F (15° to 25°C).
  • No measuring required. Just twist, squeeze, and mix.
  • Small enough to fit in your pocket.
  • Single-use container is for patients who weigh more than 33 lb (15 kg).
Sucraid Single-Use Container

Discover the Convenience of Sucraid® Single-Use Container

  • Three-day room temperature stability
    59°F to 77°F (15° to 25°C).
  • No measuring required. Just twist, squeeze, and mix.
  • Small enough to fit in your pocket.
  • Single-use container is for patients who weigh more than 33 lb (15 kg).

Traveling with Sucraid® Single-Use Container

Learn How to Order Sucraid® from Our Specialty Pharmacy

Important Safety Information for Sucraid® (sacrosidase) Oral Solution

  • Sucraid® may cause a serious allergic reaction. Patients should stop taking Sucraid® and get emergency help immediately if any of the following side effects occur: difficulty breathing, wheezing, or swelling of the face. Care should be taken when administering initial doses of Sucraid® to observe any signs of acute hypersensitivity reaction.
  • Do not use Sucraid® with patients known to be hypersensitive to yeast, yeast products, papain, or glycerin (glycerol).
  • Although Sucraid® provides replacement therapy for the deficient sucrase, it does not provide specific replacement therapy for the deficient isomaltase.
  • Adverse reactions as a result of taking Sucraid® may include worse abdominal pain, vomiting, nausea, diarrhea, constipation, difficulty sleeping, headache, nervousness, and dehydration.
  • Before prescribing Sucraid® to diabetic patients, the physician should consider that Sucraid® will enable sucrose hydrolysis and the absorption of those hydrolysis products, glucose and fructose.
  • The effects of Sucraid® have not been evaluated in patients with secondary (acquired) disaccharidase deficiency.
  • DO NOT HEAT SOLUTIONS CONTAINING SUCRAID®. Do not put Sucraid® in warm or hot fluids. Do not reconstitute or consume Sucraid® with fruit juice since the acidity of the juice may reduce the enzyme activity of Sucraid®. Half of the reconstituted Sucraid® should be taken at the beginning of the meal or snack and the other half during the meal or snack.
  • Sucraid® should be refrigerated at 36°F-46°F (2°C-8°C) and should be protected from heat and light.

Indication

Sucraid®(sacrosidase) Oral Solution is an enzyme replacement therapy for the treatment of genetically determined sucrase deficiency, which is part of Congenital Sucrase-Isomaltase Deficiency (CSID).